STOCKHOLM - February 29, 2024 - Inify Laboratories, a unique laboratory service
provider within pathology and cancer diagnostics, saw important pieces fall into
place during the fourth quarter, the foremost being our attainment of
accreditation as a medical laboratory. This paved the way for making Inify's
diagnostic service fully available to both private and public healthcare
providers, resulting in a sales growth of 176% compared to the third quarter.

"I dare to claim that our operations are unique - in Sweden, and
internationally. Our ambition is to stay at the forefront in terms of response
times, quality and user-friendliness, for both customers and employees," says
CEO Fredrik Palm at Inify Laboratories. "I've said it before - we're just
getting started."

In general, the healthcare sector struggles with high workload, long waiting
times and inconsistent quality - challenges that certainly apply to prostate
cancer diagnostics. Swedish guidelines state that a patient should receive their
test results within 11 days from sampling